Time: Nov 8, 2024, 2:00 PM EST

Speaker: Deli Wang

The objectives of this webinar are to provide detailed information for standard late-stage clinical trials design and understand main components for the sample size determination for late-stage clinical trials. The study design will focus on Phase 2 and Phase 3 trial designs for continuous, binary or time-to-event endpoints. Parameters needed for the sample size determination for clinical trials are discussed and separate examples will be used to demonstrate how to calculate sample size for Phase 3 superiority trials with continuous endpoint, binary endpoint and time-to-event endpoint.